Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Paypal (PYPL) Stock Moves -1.64%: What You Should Know By Zacks Investment Research - Mar 23, 2020

Paypal (PYPL) closed at $85.26 in the latest trading session, marking a -1.64% move from the prior day. This change was narrower than the S&P 500's daily loss of 2.93%. Elsewhere, the Dow lost...

Owens & Minor (OMI) Stock Moves -1.35%: What You Should Know By Zacks Investment Research - Mar 23, 2020

Owens & Minor (OMI) closed at $5.83 in the latest trading session, marking a -1.35% move from the prior day. This change was narrower than the S&P 500's 2.93% loss on the day. Meanwhile, the...

Nokia (NOK) Stock Moves -0.38%: What You Should Know By Zacks Investment Research - Mar 23, 2020

Nokia (HE:NOKIA) (NOK) closed the most recent trading day at $2.65, moving -0.38% from the previous trading session. This change was narrower than the S&P 500's 2.93% loss on the day. Elsewhere,...

Invitae (NVTA) Stock Moves -0.59%: What You Should Know By Zacks Investment Research - Mar 23, 2020

In the latest trading session, Invitae (NVTA) closed at $10.09, marking a -0.59% move from the previous day. This change was narrower than the S&P 500's daily loss of 2.93%. At the same time, the...

Audioeye, Inc. (AEYE) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 23, 2020

Audioeye, Inc. (AEYE) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.15 per share a year ago. These figures are...

One Thing We Know For Sure By Zacks Investment Research - Mar 23, 2020

The Fed has taken another unprecedented measure today, limitless asset buying (unlimited QE), which will include US treasuries, mortgage price security, some types of corporate bonds, and municipal...

Invest In These Cash-Like ETFs By Zacks Investment Research - Mar 23, 2020

With the spread of coronavirus pandemic, the total number of confirmed cases globally topped 300,000 with more than 13,000 deaths. While the United States reported the third-highest toll of infected...

Top Research Reports For Bristol-Myers, BHP & CVS By Zacks Investment Research - Mar 23, 2020

Monday, March 23, 2020The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bristol-Myers...

Glaxo's Long-Acting HIV Regimen Cabenuva Gets Canada's Nod By Zacks Investment Research - Mar 23, 2020

GlaxoSmithKline plc’s (NYSE:GSK) HIV subsidiary, ViiV Healthcare announced that regulatory authorities in Canada have granted approval to its long-acting injectable regimen of cabotegravir and...

Coronavirus Bumps Up Grocery Stores Stocks: 4 Best Bets   By Zacks Investment Research - Mar 23, 2020

Homebound Americans are fueling strong demand for groceries as they avoid stepping outdoors over fears of contracting the novel coronavirus. In addition, of the majority of companies in the country...

Delek Gulps Poison Pill After Icahn Buys 14.8% Of Its Stake By Zacks Investment Research - Mar 23, 2020

Delek US Holdings, Inc. (NYSE:DK) recently announced its adoption of a limited-duration stockholder rights plan and declared a dividend of one "Right" for each outstanding share of Delek common...

Wall Street Saw Worst Week Since 2008: Top ETF Stories By Zacks Investment Research - Mar 23, 2020

U.S. equities logged its worst week since the recession of 2008 amid the aggravating coronavirus concerns. The S&P 500, the Dow Jones and the Nasdaq composite added 15%, 17.3% and 12.6% last week....

Continue with Apple
Continue with Google
or
Sign up with Email